|
|
The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.
After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.
Medication errors are more common among seriously ill patients than with those with minor conditions.
Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.
In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.